Sharp Clinical

Partner Content

Artificial intelligence is welcome, but minimization isn’t? A clinical paradox

Sharp explores how artificial intelligence is used in clinical trial services, and why companies are resistant to Minimization.

Partner Content

Forced degradation studies: A critical lens into pharmaceutical stability

Partner Content

Dangerous goods in DCTs: Key takeaways from a real-world direct-to-patient experience

Partner Content

CDMO insights podcast series: Our Experience is Your Strength | Episode #3 Clinical Forecasting, Packaging & Distribution

Partner Content

IRT/RTSM: Key factors you need to know before choosing a solution for your trial

Partner Content

7 key questions to consider for your next IND filing

Partner Content

Clinical trial challenges in China: How a Sharp and ClinsChain pairing is breaking down barriers

Partner Content

Demystifying the role of the QP in the clinical trial supply chain

Partner Content

The pros and cons of pooling supplies for clinical trials

Partner Content

Analytical testing: Ten questions that accelerate drug development

Partner Content

Delivering the direct-to-patient promise: Are regulatory and tech challenges standing in the way?

Miranda McLaren

Partner Content

Why demand is rising for secure and climate-controlled gene therapy services

Miranda McLaren

Features

Sustainable supply chains: clinical trials in a new era of limited resources

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close